These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8018948)

  • 1. Molecular cytogenetics: solid tumors and leukemia.
    Gray JW; Pallavicini MG
    Blood Cells; 1993; 19(3):677-83; discussion 687-9. PubMed ID: 8018948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of current molecular cytogenetic protocols for the diagnosis of chromosome aberrations in tumor specimens.
    Lichter P; Fischer K; Joos S; Fink T; Baudis M; Potkul RK; Ohl S; Solinas-Toldo S; Weber R; Stilgenbauer S; Bentz M; Döhner H
    Cytokines Mol Ther; 1996 Sep; 2(3):163-9. PubMed ID: 9384700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular cytogenetics.
    Kearney L
    Best Pract Res Clin Haematol; 2001 Sep; 14(3):645-69. PubMed ID: 11640874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence in situ hybridization (FISH) in cytogenetics of leukemia.
    Michalová K
    Folia Biol (Praha); 1996; 42(6):311-4. PubMed ID: 9158941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous detection of multiple genetic aberrations in single cells by spectral fluorescence in situ hybridization.
    Slovak ML; Tcheurekdjian L; Zhang FF; Murata-Collins JL
    Cancer Res; 2001 Feb; 61(3):831-6. PubMed ID: 11221864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interphase cytogenetics--a new technique for analysis of acquired genetic changes in tumor cells].
    Schousboe K; Brøndum-Nielsen K
    Ugeskr Laeger; 1993 Dec; 155(51):4158-62. PubMed ID: 8273238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of specific cytologic, cytogenetic and molecular-cytogenetic techniques for the characterization of solid tumors.
    Schwanitz G; Raff R
    Rocz Akad Med Bialymst; 2005; 50():91-6. PubMed ID: 16358945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FISH panels for hematologic malignancies.
    Sreekantaiah C
    Cytogenet Genome Res; 2007; 118(2-4):284-96. PubMed ID: 18000382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetics. An evolving role in the diagnosis and treatment of cancer.
    Glassman AB
    Clin Lab Med; 1997 Mar; 17(1):21-37. PubMed ID: 9138897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescent in situ hybridization as an adjunct to conventional cytogenetics.
    Mark HF
    Ann Clin Lab Sci; 1994; 24(2):153-63. PubMed ID: 8203823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosomal heterogeneity of aneuploid leukemic cell populations detected by conventional karyotyping and by fluorescence in situ hybridization (FISH).
    Gebhart E; Trautmann U; Reichardt S; Liehr T
    Anticancer Res; 1993; 13(5C):1857-62. PubMed ID: 8267393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular cytogenetics in metaphase and interphase cells for cancer and genetic research, diagnosis and prognosis. Application in tissue sections and cell suspensions.
    Mühlmann M
    Genet Mol Res; 2002 Jun; 1(2):117-27. PubMed ID: 14963837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and monitoring of chromosome aberrations in hematological malignancies by fluorescence in situ hybridization.
    Döhner H; Stilgenbauer S; Fischer K; Schröder M; Bentz M; Lichter P
    Stem Cells; 1995 Dec; 13 Suppl 3():76-82. PubMed ID: 8747992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward the validation of aneusomy detection by fluorescence in situ hybridization in bladder cancer: comparative analysis with cytology, cytogenetics, and clinical features predicts recurrence and defines clinical testing limitations.
    Zhang FF; Arber DA; Wilson TG; Kawachi MH; Slovak ML
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2317-28. PubMed ID: 9815630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of numerical aberrations in hematologic neoplasias by fluorescence in situ hybridization.
    Cuneo A; Bigoni R; Roberti MG; Bardi A; Balsamo R; Piva N; Castoldi G
    Haematologica; 1997; 82(1):85-90. PubMed ID: 9107092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetics and genetics of human cancer: methods and accomplishments.
    Sandberg AA; Meloni-Ehrig AM
    Cancer Genet Cytogenet; 2010 Dec; 203(2):102-26. PubMed ID: 21156223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The current state of molecular cytogenetics in cancer diagnosis.
    Liehr T; Othman MA; Rittscher K; Alhourani E
    Expert Rev Mol Diagn; 2015 Apr; 15(4):517-26. PubMed ID: 25664836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of fluorescence in situ hybridization for the detection of genomic aberrations in older patients with acute myeloid leukemia.
    Fröhling S; Kayser S; Mayer C; Miller S; Wieland C; Skelin S; Schlenk RF; Döhner H; Döhner K;
    Haematologica; 2005 Feb; 90(2):194-9. PubMed ID: 15710571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative genomic hybridization as a tool in tumour cytogenetics.
    James LA
    J Pathol; 1999 Mar; 187(4):385-95. PubMed ID: 10398096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphoma cytogenetics.
    Dave BJ; Nelson M; Sanger WG
    Clin Lab Med; 2011 Dec; 31(4):725-61, x-xi. PubMed ID: 22118746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.